At a recent industry event, the 14th Annual Bioprocessing Summit in Boston, scientists discussed a variety of advances in gene therapy manufacturing. To learn more about these advances, GEN talked ...

High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...

Adeno-associated viruses (AAV) have emerged as pivotal delivery vehicles for gene therapy due to their overall safety (less immunogenic), efficiency (broad tropism), and long-term gene expression.

Viral vectors have become increasingly used in biotherapies research and development, and adeno-associated virus (AAV) is now the main vector for gene therapy. Different AAV production platforms can ...

Pharmaron Biologics, Liverpool, UK, is a commercial development and manufacturing organization (CDMO) that offers a range of unique end-to-end laboratory services for the development and manufacture ...

The project aims to demonstrate the scalability & reproducibility of Exothera's AAV production processes from small scale (1-2 L) up to 2,000L bioreactor scale. Exothera will lead the project at its ...

Cell and gene therapies (CGTs) have begun to transform the landscape of therapeutic offerings for patients with genetic diseases and other medical conditions. For many emerging biopharmaceutical ...

AJDOVŠČINA, Slovenia--(BUSINESS WIRE)--BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of CORNERSTONE AAV Process Development ...

COLUMBUS, Ohio, March 25, 2024 /PRNewswire/ -- Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has ...